Rein Therapeutics (RNTX) Stock Forecast & Price Target

RNTX Forecast - Frequently Asked Questions

Should I buy or sell Rein Therapeutics stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Rein Therapeutics in the last year. There is currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" RNTX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RNTX, but not buy additional shares or sell existing shares.

Does Rein Therapeutics's stock price have much downside?

According to analysts, Rein Therapeutics's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Has Rein Therapeutics been downgraded by Wall Street analysts recently?

Over the previous 90 days, Rein Therapeutics's stock had 1 downgrade by analysts.

What analysts cover Rein Therapeutics?

Rein Therapeutics has been rated by research analysts at Brookline Capital Management in the past 90 days.

Do Wall Street analysts like Rein Therapeutics more than its competitors?

Analysts like Rein Therapeutics less than other "medical" companies. The consensus rating for Rein Therapeutics is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how RNTX compares to other companies.